Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Schultz

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.
Blood|April 26, 2011
Genetic predictors for stroke in children with sickle cell anemiaJonathan M Flanagan, Denise M Frohlich, Thad A Howard, et al.
British Journal of Haematology|July 22, 2021
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trialAngela Rankine-Mullings, Marvin Reid, Deanne Soares, et al.
Blood|June 11, 2014
Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trialKathleen J Helton, Robert J Adams, Karen L Kesler, et al.
British Journal of Haematology|January 24, 2015
Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overloadBanu Aygun, Nicole A Mortier, Karen Kesler, et al.
American Journal of Hematology|June 20, 2015
Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trialJohn C Wood, Sara Pressel, Zora R Rogers, et al.
Blood Advances|January 17, 2025
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trialRosa M Nieves, Teresa Latham, Nicolle Marte, et al.
Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.
Blood|April 26, 2011
Genetic predictors for stroke in children with sickle cell anemiaJonathan M Flanagan, Denise M Frohlich, Thad A Howard, et al.
British Journal of Haematology|July 22, 2021
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trialAngela Rankine-Mullings, Marvin Reid, Deanne Soares, et al.
Blood|June 11, 2014
Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trialKathleen J Helton, Robert J Adams, Karen L Kesler, et al.
British Journal of Haematology|January 24, 2015
Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overloadBanu Aygun, Nicole A Mortier, Karen Kesler, et al.
American Journal of Hematology|June 20, 2015
Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trialJohn C Wood, Sara Pressel, Zora R Rogers, et al.
Blood Advances|January 17, 2025
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trialRosa M Nieves, Teresa Latham, Nicolle Marte, et al.
Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.
Pageof 2